The critical function of ZFP36L2 in cisplatin treatment in particular might have a huge impact on its comprehensive clinical application, as cisplatin-based chemotherapy is utilized widely as a standard anti-cancer therapy for many common carcinomas, including non-small cell lung cancer, ovarian cancer, esophageal cancer, and cervical cancer. The gene discussed is ZFP36L2; the disease is ovarian carcinoma.